CogenTech offers a cloud‑native platform that centralizes clinical trial governance and execution for medical device sponsors. Using AI‑driven analytics and digital coordination tools, it automates risk detection, stakeholder communication, and compliance tracking across a network of 500+ sites, aligning its performance with sponsor outcomes through a shared‑risk model.
Funding
Funding not disclosed
Founders
Product
Problem
Medical technology sponsors often face fragmented clinical trial execution, with manual processes, unclear governance, and high operational noise that lead to reactive management, compliance risks, and unpredictable timelines.
Solution
CogenTech functions as a digital-first Program Management Organization that centralizes clinical trial governance, execution frameworks, and stakeholder coordination within a cloud-based platform. The platform leverages artificial intelligence and data analytics to provide real-time insights, automate risk identification, and streamline communication across sites. By defining ownership, accountability, and escalation pathways, CogenTech transforms trial programs into integrated execution systems that enable proactive, risk‑aware decision making. The shared‑risk model aligns incentives with sponsors, shifting from reactive oversight to predictable, compliant program delivery.
Target Audience
Primary customers are medical technology companies and device sponsors that run multi‑site clinical programs and require a unified, technology‑enabled PMO to manage trial execution, compliance, and risk.
Features
- Cloud-native, self‑servicing portal that consolidates trial plans, governance documents, and status dashboards in a single view
- AI‑driven analytics that surface operational risks early and generate actionable alerts for stakeholders
- Structured execution frameworks with defined ownership, accountability, and escalation pathways to ensure compliance and traceability
- Digital coordination tools that reduce operational noise by automating stakeholder communications and task assignments
- Integrated network of 500+ clinical sites and a pool of 5,000+ subjects to accelerate site onboarding and diversify study populations
- Shared‑risk engagement model that aligns CogenTech’s performance with sponsor outcomes